Back to Journals » International Journal of Nanomedicine » Volume 15

Delivery of MSCs with a Hybrid β-Sheet Peptide Hydrogel Consisting IGF-1C Domain and D-Form Peptide for Acute Kidney Injury Therapy [Corrigendum]

Authors Wang H, Shang Y, Chen X, Wang Z, Zhu D, Liu Y, Zhang C, Chen P, Wu J, Wu L, Kong D, Yang Z, Li Z, Chen X

Received 20 October 2020

Accepted for publication 20 October 2020

Published 2 November 2020 Volume 2020:15 Pages 8569—8570

DOI https://doi.org/10.2147/IJN.S287765


Wang H, Shang Y, Chen X, et al. Int J Nanomedicine. 2020;15:4311—4324.

The authors have advised Figure 5A on page 4320 is incorrect. Due to an error at the time of figure assembly SHAM and MSC/Gel in the Masson row were duplicated. The correct Figure 5 is shown below.

The authors apologize for this error and advise it does not affect the results of the paper.


Read the original article

Wang H, Shang Y, Chen X, et al. Int J Nanomedicine. 2020;15:4311—4324.

The authors have advised Figure 5A on page 4320 is incorrect. Due to an error at the time of figure assembly SHAM and MSC/Gel in the Masson row were duplicated. The correct Figure 5 is shown below.

Figure 5 Attenuated renal fibrosis. (A) Representative images of kidney sections stained for Masson trichrome and immunofluorescence images of collagen IV at day 28 after acute kidney injure (AKI), while nuclei were counter stained with 4, 6-diamino-2-phenyl indole (DAPI). Scale bar=50 μm (upper panel) or, 100 μm (lower panel). (B) Semiquantitative analysis of Masson staining via Image J software. (C) Integrated optical density (IOD) values of collagen IV, as an equivalent to kidney fibrosis. Data mentioned above are expressed as the mean ± SEM. $P<0.05 versus phosphate buffered solution (PBS); #P<0.05 versus human placenta-derived mesenchymal stem cells (hP-MSCs); *P<0.05 versus β-IGF-1C; &P<0.05 versus β-IGF-1C+hP-MSCs.

The authors apologize for this error and advise it does not affect the results of the paper.

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]